Corneal permeability to and ocular metabolism of phenyl substituted prostaglandin esters in vitro
- 30 April 1994
- journal article
- Published by Elsevier in Prostaglandins, Leukotrienes & Essential Fatty Acids
- Vol. 50 (4) , 161-168
- https://doi.org/10.1016/0952-3278(94)90139-2
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Phenyl-substituted prostaglandins: potent and selective antiglaucoma agentsJournal of Medicinal Chemistry, 1993
- Intraocular Pressure Reduction With PhXA34, a New Prostaglandin Analogue, in Patients With Ocular HypertensionArchives of Ophthalmology (1950), 1992
- PhXA34--a prostaglandin F2 alpha analogue. Effect on intraocular pressure in patients with ocular hypertension.British Journal of Ophthalmology, 1992
- Presence of a 15-Ketoprostaglandin Delta13-Reductase in Porcine Cornea.Acta Chemica Scandinavica, 1992
- Phenyl substituted prostaglandin analogs for glaucoma treatmentDrugs of the Future, 1992
- PhXA34, a New Potent Ocular Hypotensive DrugArchives of Ophthalmology (1950), 1991
- Prostaglandin biosynthesis and its regulation in the bovine endometrium: A comparison between nonpregnant and pregnant statusTheriogenology, 1987
- Permeability of prostaglandin F2α and prostaglandin F2α esters across cornea in vitroInternational Journal of Pharmaceutics, 1986
- Esterase distribution in the rabbit cornea and its implications in ocular drug bioavailabilityBiopharmaceutics & Drug Disposition, 1982
- Inactivation of prostaglandin E1 by ocular tissues in vitroExperimental Eye Research, 1974